Jim Tananbaum, Foresite Capital Founder on Healthcare & Life Sciences

Jim Tananbaum is the founder and CEO of Foresite Capital, a U.S.-focused healthcare investment firm he launched in 2011 that manages approximately $3.5 billion in assets. With a career spanning three decades, Jim has partnered with some of the fastest-growing and most influential healthcare companies of their generation, including 10x Genomics, Amerigroup, and Jazz Pharmaceuticals. A lifelong student of both data science and medicine, his vision for Foresite Capital is to sit at the intersection of biology, technology, and data to support entrepreneurs building transformative healthcare solutions. Earlier in his career, he co-founded GelTex Pharmaceuticals and Theravance, companies that together delivered blockbuster drugs and multibillion-dollar market capitalizations. Jim holds a BS and BSEE from Yale, an MD from Harvard Medical School, and an MBA from Harvard Business School, where he was also part of the Harvard/MIT HST Program.Topics:

• Recent $900M fundraise and bets on Alumis, Latigo Biotherapeutics, Xaira Therapeutics
• 50+ IPOs, 47 public listings, 58 FDA approvals across portfolio
• Foresite Labs incubating ML-powered healthcare startups

#BiotechInvesting #AIBiotech #ForesiteCapital #JimTananbaum #HealthcareInnovation